Citigroup Inc Bristol Myers Squibb CO Put Options Transaction History

Citigroup Inc

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 10, 2024	SELL	$47.98 - $54.4 $12.4 Million - $14.1 Million	-259,100 Reduced 94.56%	14,900 $808,000
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $57.8 Million - $68.9 Million	-1,191,500 Reduced 81.3%	274,000 $14.1 Million
Q3 2023 Nov 09, 2023	BUY	$57.89 - $64.73 $56.7 Million - $63.4 Million	979,900 Added 201.79%	1,465,500 $85.1 Million
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $11.2 Million - $12.4 Million	175,500 Added 56.59%	485,600 $31.1 Million
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $38.4 Million - $43.5 Million	-584,300 Reduced 65.33%	310,100 $21.5 Million

Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $12.7 Million - $15.1 Million	185,900 Added 26.24%	894,400 $64.3 Million
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $19,045 - $11.3 Million	-146,500 Reduced 17.13%	708,500 $50.4 Million
Q2 2022 Aug 10, 2022	SELL	$72.62 - $79.98 $60.6 Million - $66.7 Million	-833,900 Reduced 49.38%	855,000 $65.8 Million
Q1 2022 May 12, 2022	BUY	$61.48 - $73.72 $20.8 Million - $25 Million	338,900 Added 25.1%	1,688,900 $123 Million
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $5.48 Million - $6.39 Million	102,200 Added 8.19%	1,350,000 $84.2 Million
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $73.8 Million - $86.5 Million	1,247,800 New	1,247,800 $73.8 Million

2,554

1.49B

25.9M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $88.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.